294 related articles for article (PubMed ID: 35091446)
1. Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.
Frizziero M; Kilgour E; Simpson KL; Rothwell DG; Moore DA; Frese KK; Galvin M; Lamarca A; Hubner RA; Valle JW; McNamara MG; Dive C
Clin Cancer Res; 2022 May; 28(10):1999-2019. PubMed ID: 35091446
[TBL] [Abstract][Full Text] [Related]
2. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination.
Mohamed A; Azmi AS; Asa SL; Tirumani SH; Mahipal A; Cjakrabarti S; Bajor D; Selfridge JE; Kaseb AO
Curr Oncol; 2022 Nov; 29(11):9018-9030. PubMed ID: 36421360
[TBL] [Abstract][Full Text] [Related]
4. Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Rekhtman N
Mod Pathol; 2022 Jan; 35(Suppl 1):36-50. PubMed ID: 34663914
[TBL] [Abstract][Full Text] [Related]
5. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
Ooki A; Osumi H; Fukuda K; Yamaguchi K
Cancer Metastasis Rev; 2023 Sep; 42(3):1021-1054. PubMed ID: 37422534
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.
Terashima T; Morizane C; Hiraoka N; Tsuda H; Tamura T; Shimada Y; Kaneko S; Kushima R; Ueno H; Kondo S; Ikeda M; Okusaka T
Neuroendocrinology; 2012; 96(4):324-32. PubMed ID: 22572060
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas.
Gile JJ; McGarrah PW; Leventakos K; Sonbol MB; Starr JS; Eiring RA; Hobday TJ; Halfdanarson TR
J Neuroendocrinol; 2023 May; 35(5):e13283. PubMed ID: 37229903
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.
Yazawa T
Pathol Int; 2015 Jun; 65(6):277-85. PubMed ID: 25708144
[TBL] [Abstract][Full Text] [Related]
11. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S
Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570
[TBL] [Abstract][Full Text] [Related]
12. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.
Cai L; Liu H; Huang F; Fujimoto J; Girard L; Chen J; Li Y; Zhang YA; Deb D; Stastny V; Pozo K; Kuo CS; Jia G; Yang C; Zou W; Alomar A; Huffman K; Papari-Zareei M; Yang L; Drapkin B; Akbay EA; Shames DS; Wistuba II; Wang T; Johnson JE; Xiao G; DeBerardinis RJ; Minna JD; Xie Y; Gazdar AF
Commun Biol; 2021 Mar; 4(1):314. PubMed ID: 33750914
[TBL] [Abstract][Full Text] [Related]
13. Extrapulmonary poorly differentiated NECs, including molecular and immune aspects.
McNamara MG; Scoazec JY; Walter T
Endocr Relat Cancer; 2020 Jul; 27(7):R219-R238. PubMed ID: 32357308
[TBL] [Abstract][Full Text] [Related]
14. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
15. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
16. Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas: A Review.
Stelwagen J; de Vries EGE; Walenkamp AME
JAMA Oncol; 2021 May; 7(5):759-770. PubMed ID: 33630040
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies.
Kawasaki K; Rekhtman N; Quintanal-Villalonga Á; Rudin CM
Nat Rev Clin Oncol; 2023 Jan; 20(1):16-32. PubMed ID: 36307533
[TBL] [Abstract][Full Text] [Related]
18. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma.
Keyhanian K; Phillips WJ; Yeung BS; Gomes M; Lo B; Sekhon HS
Diagn Pathol; 2022 May; 17(1):46. PubMed ID: 35538551
[TBL] [Abstract][Full Text] [Related]
20. DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Yao J; Bergsland E; Aggarwal R; Aparicio A; Beltran H; Crabtree JS; Hann CL; Ibrahim T; Byers LA; Sasano H; Umejiego J; Pavel M
Oncologist; 2022 Nov; 27(11):940-951. PubMed ID: 35983951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
